FDA gives high marks to CBD/hemp and marijuana for medical use
Garden City Park, NY: Just in time for National Weed Day (4/20), it has been reported that the Food and Drug Administration (FDA) is on its way towards approval of the first CBD oil (Cannabidiol) marijuana-based drug. Given the name of Epidiolex by the company GW Pharmaceuticals, it has been designed and approved only to help young children who suffer severe seizures caused by epilepsy. The success of the drug when treating this illness has now been crystallized by the story of sixteen-year-old Sam Vogelstein, who appeared yesterday (April 19) before a FDA panel in Washington, DC and testified that the drug has kept his severe seizures at bay for more than two years.
Though this marijuana-based medication does not contain the plant's naturally-occurring compound known as THC (tetrahydrocannabidinol, which acts as an intoxicant), its total effectiveness speaks volumes about the various beneficial uses that hemp CBD oil and medical marijuana have been proven to provide to those who suffer with any number of serious health conditions. Whether it be Alzheimer's or lung cancer, HIV/AIDS or multiple sclerosis (MS), diabetes or PTSD, or even Parkinson's or stroke, the cannabis plant has been shown time and time again to do more good for peoples' health than bad.
In light of this positive announcement, Square One has two books that will further inform and educate those who may wish to learn more about the restorative effects of cannabis on many health concerns. Healing with Hemp CBD Oil (Square One, $16.95 USD - ISBN: 978-0-7570-0455-1) from bestselling health author Dr. Earl Mindell takes a close and comprehensive look at marijuana's cousin, hemp, and the many uses of hemp oil and CBD for many of our biggest health issues, from arthritis to depression to heart disease.
Also available is Healing with Medical Marijuana (Square One, $16.95 USD - ISBN: 978-0-7570-0441-4) from fellow bestselling author Dr. Mark Sircus. The book reveals and explains the many virtues that reside at the foundation of medical marijuana use across a wide spectrum of health ills and woes. It also addresses the many deliberate distortions of perception applied by the Federal government to the general public after it outlawed marijuana in 1937. Now that the FDA has voiced its approval of a marijuana-based medication, though, we may now see in our country the steady reversal of Federal law against the use of what has been shown across time—and across the world—to be a steady help to so many.